Versikine increases Interferon Regulatory Factor 8 (IRF8) expression in macrophages, promoting the generation of CD103+ CD11c+ MHCIIhi conventional dendritic cells (cDCs), which play a key role in anti-tumor immunity 784. The gene discussed is IRF8; the disease is neoplasm.